The purpose of this study is to observe the safety and effectiveness of Remicade Injection (infliximab) under actual conditions of use in patients, and to learn more about its side effects. Patients with ankylosing spondylitis will have 6 Remicade injections and be observed for 24-30 weeks. Patients with rheumatoid arthritis will have 6 Remicade injections and be observed for 30 weeks. Patients will be observed for side effects and disease activity.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00760669?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
